Cargando…

Accurate delivery of pristimerin and paclitaxel by folic acid-linked nano-micelles for enhancing chemosensitivity in cancer therapy

Chemoresistance remains a huge challenge for effective treatment of non-small cell lung cancer (NSCLC). Previous studies have shown Chinese herbal extracts possess great potential in ameliorating tumor chemoresistance, however, the efficacy is clinically limited mainly because of the poor tumor-targ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chao, Du, Shiyu, Zhong, Wu, Liu, Kunguo, Qu, Lihua, Chu, Feiyi, Yang, Jingjing, Han, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2022
Materias:	Full Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700544/ https://www.ncbi.nlm.nih.gov/pubmed/36427092 http://dx.doi.org/10.1186/s40580-022-00343-5

Ejemplares similares

Novel amphiphilic folic acid-cholesterol-chitosan micelles for paclitaxel delivery
por: Cheng, Li-Chun, et al.
Publicado: (2016)

Amphiphilic Polymeric Micelles Based on Deoxycholic Acid and Folic Acid Modified Chitosan for the Delivery of Paclitaxel
por: Li, Liang, et al.
Publicado: (2018)

Chemosensitizing indomethacin-conjugated dextran-based micelles for effective delivery of paclitaxel in resistant breast cancer therapy
por: Ji, Weiping, et al.
Publicado: (2017)

Pristimerin Causes G1 Arrest, Induces Apoptosis, and Enhances the Chemosensitivity to Gemcitabine in Pancreatic Cancer Cells
por: Wang, Yongwei, et al.
Publicado: (2012)

Antifungal Activity of Maytenin and Pristimerin
por: Gullo, Fernanda P., et al.
Publicado: (2012)

Pristimerin, a triterpene that inhibits monoacylglycerol lipase activity, prevents the development of paclitaxel-induced allodynia in mice
por: Al-Romaiyan, Altaf, et al.
Publicado: (2022)

Folic acid conjugation improves the bioavailability and chemosensitizing efficacy of curcumin-encapsulated PLGA-PEG nanoparticles towards paclitaxel chemotherapy
por: Thulasidasan, Arun Kumar T., et al.
Publicado: (2017)

Folate-mediated targeted and intracellular delivery of paclitaxel using a novel deoxycholic acid-O-carboxymethylated chitosan–folic acid micelles
por: Wang, Feihu, et al.
Publicado: (2012)

Combination of pristimerin and paclitaxel additively induces autophagy in human breast cancer cells via ERK1/2 regulation
por: Lee, Younju, et al.
Publicado: (2018)

Folic acid-targeted disulfide-based cross-linking micelle for enhanced drug encapsulation stability and site-specific drug delivery against tumors
por: Zhang, Yumin, et al.
Publicado: (2016)

Folic acid modified TPGS as a novel nano-micelle for delivery of nitidine chloride to improve apoptosis induction in Huh7 human hepatocellular carcinoma
por: Li, Danni, et al.
Publicado: (2021)

Antitumor effects of pristimerin on human osteosarcoma cells in vitro and in vivo
por: Mori, Yuki, et al.
Publicado: (2017)

Anti-Cancer Effects of Pristimerin and the Mechanisms: A Critical Review
por: Li, Jia-jun, et al.
Publicado: (2019)

Cellular and Molecular Mechanisms of Pristimerin in Cancer Therapy: Recent Advances
por: Chen, Run-Ze, et al.
Publicado: (2021)

The effect of propofol on chemosensitivity of paclitaxel in cervical cancer cells
por: Jin, Yanshan, et al.
Publicado: (2023)

Receptor-mediated gene delivery by folic acid-modified stearic acid-grafted chitosan micelles
por: Du, Yong-Zhong, et al.
Publicado: (2011)

Intelligent nanotherapeutic strategies for the delivery of CRISPR system
por: Chen, Chao, et al.
Publicado: (2023)

A biomimetic and pH-sensitive polymeric micelle as carrier for paclitaxel delivery
por: Ma, Boxuan, et al.
Publicado: (2018)

Sodium cholate-enhanced polymeric micelle system for tumor-targeting delivery of paclitaxel
por: Zhang, Xiaomin, et al.
Publicado: (2017)

Redox-sensitive micelles for targeted intracellular delivery and combination chemotherapy of paclitaxel and all-trans-retinoid acid
por: Han, Lingfei, et al.
Publicado: (2019)

Pristimerin as a Novel Hepatoprotective Agent Against Experimental Autoimmune Hepatitis
por: El-Agamy, Dina S., et al.
Publicado: (2018)

Apatinib enhances chemosensitivity of gastric cancer to paclitaxel and 5-fluorouracil
por: Xu, Zhiyuan, et al.
Publicado: (2019)

Folic Acid-Targeted Disulfide-Based Cross-Linking Micelle for Enhanced Drug Encapsulation Stability and Site-Specific Drug Delivery Against Tumors [Corrigendum]
Publicado: (2021)

Photosensitizer Micelles Together with IDO Inhibitor Enhance Cancer Photothermal Therapy and Immunotherapy
por: Peng, Jinrong, et al.
Publicado: (2018)

Bioavailability Enhancement of Paclitaxel via a Novel Oral Drug Delivery System: Paclitaxel-Loaded Glycyrrhizic Acid Micelles
por: Yang, Fu-Heng, et al.
Publicado: (2015)

PEG-Farnesyl Thiosalicylic Acid Telodendrimer Micelles as an Improved Formulation for Targeted Delivery of Paclitaxel
por: Zhang, Xiaolan, et al.
Publicado: (2014)

Polymeric Micelles Based on Modified Glycol Chitosan for Paclitaxel Delivery: Preparation, Characterization and Evaluation
por: Liang, Na, et al.
Publicado: (2018)

Co-Delivery of Paclitaxel and Doxorubicin by pH-Responsive Prodrug Micelles for Cancer Therapy
por: Jiang, Yanhua, et al.
Publicado: (2020)

A Multifunctional Polymeric Micelle for Targeted Delivery of Paclitaxel by the Inhibition of the P-Glycoprotein Transporters
por: Razzaq, Sobia, et al.
Publicado: (2021)

Pristimerin, a Triterpenoid, Inhibits Tumor Angiogenesis by Targeting VEGFR2 Activation
por: Mu, Xianmin, et al.
Publicado: (2012)

Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss
por: Qi, Dahu, et al.
Publicado: (2021)

Folic acid-modified reverse micelle-lipid nanocapsules overcome intestinal barriers and improve the oral delivery of peptides
por: He, Jibiao, et al.
Publicado: (2023)

Folic acid functionalization for targeting self-assembled paclitaxel-based nanoparticles
por: Colombo, Eleonora, et al.
Publicado: (2022)

c(RGDyK)-decorated Pluronic micelles for enhanced doxorubicin and paclitaxel delivery to brain glioma
por: Huang, YuKun, et al.
Publicado: (2016)

Versatile flexible micelles integrating mucosal penetration and intestinal targeting for effectively oral delivery of paclitaxel
por: Liu, Chao, et al.
Publicado: (2023)

Liposome-Micelle-Hybrid (LMH) Carriers for Controlled Co-Delivery of 5-FU and Paclitaxel as Chemotherapeutics
por: Hassan, Md. Musfizur, et al.
Publicado: (2023)

Pristimerin induces apoptosis and inhibits proliferation, migration in H1299 Lung Cancer Cells
por: Li, Jiajun, et al.
Publicado: (2020)

Enhancement of Anti-Tumoral Properties of Paclitaxel Nano-Crystals by Conjugation of Folic Acid to Pluronic F127: Formulation Optimization, In Vitro and In Vivo Study
por: Sreeharsha, Nagaraja, et al.
Publicado: (2022)

Correction: Paclitaxel prodrug based mixed micelles for tumor-targeted chemotherapy
por: Tang, Dongyang, et al.
Publicado: (2020)

β-Cyclodextrin-Based Inclusion Complexation Bridged Biodegradable Self-Assembly Macromolecular Micelle for the Delivery of Paclitaxel
por: Chen, Yanzuo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vcut8gj4kcb1bscpmq7r8p84on